Modulation of rat hepatic CYP3A4 activity by Brassica oleracea, Hibiscus rosa sinensis, and Tradescantia zebrina

被引:0
|
作者
Han, Chin Jin [1 ]
Akowuah, Gabriel Akyirem [2 ]
Shukkoor, Mohamed Saleem Abdul [2 ]
Biswas, Anupam [1 ]
机构
[1] MAHSA Univ, Fac Med Biosci & Nursing, Bandar Saujana Putra Campus,Jalan SP2, Kuala Langat 42610, Selangor, Malaysia
[2] UCSI Univ, Fac Pharmaceut Sci, 1 Jalan Menara Gading, Kuala Lumpur 56000, Malaysia
来源
关键词
Brassica oleracea; CYP3A4; Hibiscus rosa; Liver; Tradescantia zebrina;
D O I
10.33263/BRIAC111.74537459
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
One of the major cytochrome P450s, CYP 3A4, is known to be involved in herb-drug and food-drug interactions. The objective of this study was to examine the in vitro effect of Brassica oleracea L. var. pekinensis (Chinese cabbage) juice, methanol extract of Hibiscus rosa sinensis (Hibiscus) yellow flower and Tradescantia zebrina pendula leaves, respectively on CYP 3A4 activity in rat liver microsomes. Differential centrifugation method was used to isolate microsomes from the rat livers. The concentration of formaldehyde released from N-demethylation of aminopyrine in rat liver microsomes was determined. Based on the results obtained, B. oleracea juice at 100 ng/mL and 1000 g/mL significantly reduced CYP3A4 activity when compared to the control group. On the other hand, methanol extract of Hibiscus yellow flower and T. zebrina leaves at 1, 10, 100, and 1000 ng/mL significantly increased the metabolism of aminopyrine by enhancing CYP3A4 activity when compared to the control group. Our findings suggested that Chinese cabbage juice, methanol extract of Hibiscus yellow flower, and T. zebrina leaves could have the potential to interact with the metabolism of aminopyrine in rat liver microsomes by modulating the hepatic CYP activity.
引用
收藏
页码:7453 / 7459
页数:7
相关论文
共 43 条
  • [31] Correlations between 4β-hydroxycholesterol and hepatic and intestinal CYP3A4: protein expression, microsomal ex vivo activity, and in vivo activity in patients with a wide body weight range
    Kine Eide Kvitne
    Kristine Hole
    Veronica Krogstad
    Birgit Malene Wollmann
    Christine Wegler
    Line K. Johnson
    Jens K. Hertel
    Per Artursson
    Cecilia Karlsson
    Shalini Andersson
    Tommy B. Andersson
    Rune Sandbu
    Jøran Hjelmesæth
    Eva Skovlund
    Hege Christensen
    Rasmus Jansson-Löfmark
    Anders Åsberg
    Espen Molden
    Ida Robertsen
    European Journal of Clinical Pharmacology, 2022, 78 : 1289 - 1299
  • [32] Correlations between 4β-hydroxycholesterol and hepatic and intestinal CYP3A4: protein expression, microsomal ex vivo activity, and in vivo activity in patients with a wide body weight range
    Kvitne, Kine Eide
    Hole, Kristine
    Krogstad, Veronica
    Wollmann, Birgit Malene
    Wegler, Christine
    Johnson, Line K.
    Hertel, Jens K.
    Artursson, Per
    Karlsson, Cecilia
    Andersson, Shalini
    Andersson, Tommy B.
    Sandbu, Rune
    Hjelmesaeth, Joran
    Skovlund, Eva
    Christensen, Hege
    Jansson-Lofmark, Rasmus
    Asberg, Anders
    Molden, Espen
    Robertsen, Ida
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (08) : 1289 - 1299
  • [33] The activity of intestinal and hepatic CYP3A4 recovers within 72 h after a strong mechanism-based inhibition caused by cobicistat
    Kaartinen, Taavi J. K.
    Tornio, Aleksi
    Lapatto-Reiniluoto, Outi
    Sodhi, Jasleen K.
    Yadav, Aprajita S.
    Isoherranen, Nina
    Niemi, Mikko
    Backman, Janne T.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2023, 132 : 21 - 21
  • [34] Ketoconazole (K) inhibition of intestinal, and hepatic cytochrome p450 3A4 (CYP3A4) activity using midazolam (M) as an in vivo probe.
    Tsunoda, SM
    Velez, RL
    Greenblatt, DJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 172 - 172
  • [35] Enhanced intrinsic CYP3A4 activity in human hepatic C3A cells with optically controlled CRISPR/dCas9 activator complex
    Han, Shuo
    Wei, Shiruo
    Wang, Xuan
    Han, Xu
    Zhang, Mingzhi
    Su, Ming
    Li, Yang
    Guo, Jinhai
    Zeng, Wotan
    Liu, Jinwen
    Gao, Yi
    Shen, Li
    INTEGRATIVE BIOLOGY, 2018, 10 (12) : 780 - 790
  • [36] Modulation of CYP3A4 and CYP2C9 activity by Bulbine natalensis and its constituents: An assessment of HDI risk of B. natalensis containing supplements
    Husain, Islam
    Manda, Vamshi
    Alhusban, Manal
    Dale, Olivia R.
    Bae, Ji-Yeong
    Avula, Bharathi
    Gurley, Bill J.
    Chittiboyina, Amar G.
    Khan, Ikhlas A.
    Khan, Shabana, I
    PHYTOMEDICINE, 2021, 81
  • [37] Microsomal enzyme induction and clinical aggravation of porphyria:: The evaluation of human urinary 6β-hydroxycortisol/cortisol ratio as the index of hepatic CYP3A4 activity
    Uejima, E
    Takahashi, K
    Morisaki, T
    Takahashi, K
    Ohno, M
    Nishida, Y
    Moriya, M
    Kaido, M
    Abe, K
    Sakoda, S
    Yanagihara, T
    Kurokawa, N
    Azuma, J
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (12): : 1374 - 1379
  • [38] Measurement of hepatic and intestinal CYP3A4 and PGP activity by combined po+iv [14C]erythromycin breath and urine test
    Lemahieu, WPD
    Maes, BD
    Ghoos, Y
    Rutgeerts, P
    Verbeke, K
    Vanrenterghem, Y
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2003, 285 (03): : G470 - G482
  • [39] Modulation of CYP3A4 activity and induction of apoptosis, necrosis and senescence by the anti-tumour imidazoacridinone C-1311 in human hepatoma cells
    Augustin, Ewa
    Pawlowska, Monika
    Polewska, Joanna
    Potega, Agnieszka
    Mazerska, Zofia
    CELL BIOLOGY INTERNATIONAL, 2013, 37 (02) : 109 - 120
  • [40] Oncoglabrinol C, a new flavan from Oncocalyx glabratus protects endothelial cells against oxidative stress and apoptosis, and modulates hepatic CYP3A4 activity
    Parvez, Mohammad K.
    Al-Dosari, Mohammed S.
    Ahmed, Sarfaraz
    Rehman, Md Tabish
    Al-Rehaily, Adnan J.
    Alajmi, Mohammed F.
    SAUDI PHARMACEUTICAL JOURNAL, 2020, 28 (06) : 648 - 656